FDAFDA · Food and drugs·Recall number D-840-2013
MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC 0310 0321 30
Published August 14, 2013 · Recall initiated: June 21, 2013
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Precipitate; potential for incomplete constitution upon addition of diluent.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Distributor
- USA and Puerto Rico
- Lot
- NDC 0310-321-30, lot JX109, expiration 2/2015; lot JY042, expiration 2/2015
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.